Levetiracetam Solution
FDA Label NDC 55154-5782

94 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Levetiracetam (NDC 55154-5782). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 partial-onset seizures, 1.2 myoclonic seizures in patients with juvenile myoclonic epilepsy, 1.3 primary generalized tonic-clonic seizures, 2.1 important administration instructions, 2.2 dosing for partial-onset seizures, adults 16 years of age and older, 1 month to < 6 months, 6 months to < 4 years, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package/Label Display Panel

NDC 55154-5782-5

LEVETIRACETAM

ORAL SOLUTION, USP

500 mg / 5 mL

5 x 5 mL UNIT DOSE CUPS

500mg/5ml Bag Label (F63f4202 D0c1 4ef3 8dc5 8bb4cab6a613 00)

500mg/5ml Bag Label (F63f4202 D0c1 4ef3 8dc5 8bb4cab6a613 00)

* Please review the disclaimer below.